ENTA
Price
$7.55
Change
+$0.05 (+0.67%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
160.32M
42 days until earnings call
VYGR
Price
$3.11
Change
+$0.15 (+5.07%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
163.24M
31 days until earnings call
Interact to see
Advertisement

ENTA vs VYGR

Header iconENTA vs VYGR Comparison
Open Charts ENTA vs VYGRBanner chart's image
Enanta Pharmaceuticals
Price$7.55
Change+$0.05 (+0.67%)
Volume$12.12K
Capitalization160.32M
Voyager Therapeutics
Price$3.11
Change+$0.15 (+5.07%)
Volume$15.81K
Capitalization163.24M
ENTA vs VYGR Comparison Chart in %
Loading...
ENTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENTA vs. VYGR commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENTA is a Buy and VYGR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (ENTA: $7.50 vs. VYGR: $2.96)
Brand notoriety: ENTA and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENTA: 150% vs. VYGR: 185%
Market capitalization -- ENTA: $160.32M vs. VYGR: $163.24M
ENTA [@Biotechnology] is valued at $160.32M. VYGR’s [@Biotechnology] market capitalization is $163.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENTA’s FA Score shows that 1 FA rating(s) are green whileVYGR’s FA Score has 2 green FA rating(s).

  • ENTA’s FA Score: 1 green, 4 red.
  • VYGR’s FA Score: 2 green, 3 red.
According to our system of comparison, VYGR is a better buy in the long-term than ENTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENTA’s TA Score shows that 5 TA indicator(s) are bullish while VYGR’s TA Score has 3 bullish TA indicator(s).

  • ENTA’s TA Score: 5 bullish, 4 bearish.
  • VYGR’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ENTA is a better buy in the short-term than VYGR.

Price Growth

ENTA (@Biotechnology) experienced а +4.46% price change this week, while VYGR (@Biotechnology) price change was -0.34% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.68%. For the same industry, the average monthly price growth was +32.84%, and the average quarterly price growth was +6.72%.

Reported Earning Dates

ENTA is expected to report earnings on Aug 11, 2025.

VYGR is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+3.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VYGR($163M) and ENTA($160M) have the same market capitalization . ENTA YTD gains are higher at: 30.435 vs. VYGR (-47.795). ENTA has higher annual earnings (EBITDA): -87.12M vs. VYGR (-97.25M). VYGR has more cash in the bank: 236M vs. ENTA (193M). VYGR has less debt than ENTA: VYGR (42M) vs ENTA (58.7M). VYGR (67M) and ENTA (64.5M) have equivalent revenues.
ENTAVYGRENTA / VYGR
Capitalization160M163M98%
EBITDA-87.12M-97.25M90%
Gain YTD30.435-47.795-64%
P/E RatioN/A6.00-
Revenue64.5M67M96%
Total Cash193M236M82%
Total Debt58.7M42M140%
FUNDAMENTALS RATINGS
ENTA vs VYGR: Fundamental Ratings
ENTA
VYGR
OUTLOOK RATING
1..100
8450
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
33
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9795
PRICE GROWTH RATING
1..100
4165
P/E GROWTH RATING
1..100
110
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VYGR's Valuation (33) in the Biotechnology industry is somewhat better than the same rating for ENTA (96). This means that VYGR’s stock grew somewhat faster than ENTA’s over the last 12 months.

VYGR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as ENTA (100). This means that VYGR’s stock grew similarly to ENTA’s over the last 12 months.

VYGR's SMR Rating (95) in the Biotechnology industry is in the same range as ENTA (97). This means that VYGR’s stock grew similarly to ENTA’s over the last 12 months.

ENTA's Price Growth Rating (41) in the Biotechnology industry is in the same range as VYGR (65). This means that ENTA’s stock grew similarly to VYGR’s over the last 12 months.

ENTA's P/E Growth Rating (1) in the Biotechnology industry is in the same range as VYGR (10). This means that ENTA’s stock grew similarly to VYGR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENTAVYGR
RSI
ODDS (%)
Bearish Trend 4 days ago
72%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
65%
Bullish Trend 4 days ago
78%
Momentum
ODDS (%)
Bullish Trend 4 days ago
66%
Bearish Trend 4 days ago
80%
MACD
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
73%
Bearish Trend 4 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
81%
Advances
ODDS (%)
Bullish Trend 6 days ago
70%
N/A
Declines
ODDS (%)
Bearish Trend 8 days ago
84%
Bearish Trend 11 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 5 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
74%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ENTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FCECX32.980.52
+1.60%
Fidelity Advisor Consumer Discret C
WGISX15.120.06
+0.40%
Wasatch International Select Instl
ODIIX129.280.32
+0.25%
Invesco Discovery R6
PHLQX41.60-0.22
-0.53%
PGIM Jennison Health Sciences R6
MDGRX29.31-0.20
-0.68%
BlackRock Natural Resources Inv A

ENTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENTA has been loosely correlated with ALEC. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ENTA jumps, then ALEC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTA
1D Price
Change %
ENTA100%
-0.13%
ALEC - ENTA
43%
Loosely correlated
-1.33%
BEAM - ENTA
39%
Loosely correlated
-1.98%
KRYS - ENTA
39%
Loosely correlated
-2.60%
ADCT - ENTA
38%
Loosely correlated
+0.37%
SCPH - ENTA
38%
Loosely correlated
-2.76%
More

VYGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with RGNX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
-0.34%
RGNX - VYGR
52%
Loosely correlated
-4.11%
TRDA - VYGR
51%
Loosely correlated
-1.57%
KYMR - VYGR
51%
Loosely correlated
-3.48%
XNCR - VYGR
48%
Loosely correlated
-3.10%
IMNM - VYGR
48%
Loosely correlated
-0.23%
More